Oestrogen receptor β is required for androgen-stimulated proliferation of LNCaP prostate cancer cells

Journal of Molecular Endocrinology

Volumn 32, Issue 3, 2004, Pages 777-791

  Maggiolini, Marcello ^a   Recchia, Anna Grazia ^a   Carpino, Amalia ^a   Vivacqua, Adele ^a   Fasanella, Giovanna ^a   Rago, Vittoria ^a   Pezzi, Vincenzo ^a   Briand, Pierre André ^b   Picard, Didier ^b   Andò, Sebastiano ^a  

^a UNIVERSITY OF CALABRIA   (Italy)

^b UNIVERSITY OF GENEVA   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

5ALPHA PREGNANE 3,20 DIONE; ANDROGEN RECEPTOR; ANTISENSE OLIGONUCLEOTIDE; BICALUTAMIDE; ESTRADIOL; ESTROGEN RECEPTOR BETA; FULVESTRANT;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL; CELL PROLIFERATION; CONTROLLED STUDY; EXPRESSION VECTOR; GENE TARGETING; GENETIC TRANSCRIPTION; HELA CELL; HORMONE ACTION; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IMMUNOCYTOCHEMISTRY; MALE; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN LOCALIZATION; QUANTITATIVE ANALYSIS; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; TRANSACTIVATION;

ANDROGEN ANTAGONISTS; ANDROGENS; ANILIDES; CELL LINE, TUMOR; CELL PROLIFERATION; DIHYDROTESTOSTERONE; ESTRADIOL; ESTROGEN ANTAGONISTS; ESTROGEN RECEPTOR BETA; GENES, REPORTER; HUMANS; MALE; OLIGONUCLEOTIDES, ANTISENSE; PROSTATIC NEOPLASMS; RECEPTORS, ANDROGEN; RESPONSE ELEMENTS;

EID: 3042753856     PISSN: 09525041     EISSN: None     Source Type: Journal    
DOI: 10.1677/jme.0.0320777     Document Type: Article

References (71)

1. Beato M 1989 Gene regulation by steroid hormones. Cell 56 335-344.
2. Beato M, Herrlich P & Schutz G 1995 Steroid hormone receptors: many actors in search of a plot. Cell 83 851-857.
3. Beato M, Chavez S & Truss M 1996 Transcriptional regulation by steroid hormones. Steroids 61 240-251.
4. Berry M, Nunez AM & Chambon P 1989 Estrogen responsive element of the human pS2 gene is an imperfectly palindromic sequence. PNAS 86 1218-1222.
5. Bonkhoff H, Fixemer T, Hunsicker I & Remberger K 1999 Estrogen receptor expression in prostate cancer and malignant prostatic lesions. American Journal of Pathology 155 641-647.
6. Brolin J, Skoog L & Ekman P 1992 Immunohistochemistry and biochemistry in detection of androgen, progesterone and estrogen receptors in benign and malignant human prostatic tissue. Prostate 20 281-295.
7. Bunone G, Briand PA, Miksicek RJ & Picard D 1996 Activation of the unliganded estrogen receptor by EGF involves the MAP kinase pathway and direct phosphorylation. EMBO 15 2174-2183.
8. Carruba G, Pfeffer U, Fecarotta E, Coviello DA, D'Amato E, Lo Castro M, Vidali G, Castagnetta L 1994 Estradiol inhibits growth of hormone non-responsive PC3 human prostate cancer cells. Cancer Research 54 1190-1193.
9. Castagnetta L, Miceli MD, Sorci CM, Pfeffer U, Farruggio R, Oliveri G, Calabro M & Carruba G 1995 Growth of LNCaP human prostate cancer cells is stimulated by estradiol via its own receptor. Endocrinology 163 2309-2319.
10. Catalona WJ 1994 Management of cancer of the prostate. New England Journal of Medicine 331 996-1004.
11. Couse JF, Lindzey J, Grandien K, Gustafsson JA & Korach KS 1997 Tissue distribution and quantitative analysis of estrogen receptor-α ERα) and estrogen receptor-β (ERβ) messenger ribonucleic acid in the wild-type and ERα knockout mouse. Endocrinology 138 4613-4621.
12. Cowley SM & Parker MG 1999 A comparison of transcriptional activation by ERα and ERβ. Journal Steroid Biochemistry and Molecular Biology 69 165-175.
13. Culig Z, Hobisch A, Cronauer MV, Cato ACB, Hittmair A, Radmayr C, Eberle J, Bartsch G & Klocker H 1993 Mutant androgen receptor detected in an advanced-stage prostatic carcinoma is activated by adrenal androgens and progesterone. Molecular Endocrinology 7 1541 1550.
14. Delaunay F, Pettersson K, Tujague M & Gustafsson JA 2000 Functional differences between the amino-terminal domains of estrogen receptors α and β. Molecular Pharmacology 58 584-590.
15. Ehara H, Koji T, Deguchi T, Yoshii A, Nakano M, Nakane PK & Kawada Y 1995 Expression of estrogen receptor in diseased human prostate assessed by non-radioactive in situ hybridization and immunohistochemistry. Prostate 27 304-313.
16. Ekena K, Katzenellenbogen JA & Katzenellenbogen BS 1998 Determinants of ligand specificity of estrogen receptor α estrogen versus androgen discrimination. Journal Biological Chemistry 273 693-699.
17. Elo JP, Kvist L, Leinonen K, Isomaa V, Henttu P, Lukkarinen O & Vihko P 1995 Mutated human androgen receptor gene detected in a prostatic cancer patient is also activated by estradiol. Journal of Clinical Endocrinology and Metabolism 80 3494-3500.
18. Enmark E, Pelto-Huikko M, Grandien K, Lagercrantz S, Lagercrantz J, Fried G, Nordenskjold M & Gustafsson JA 1997 Human estrogen receptor beta-gene structure, chromosomal localization and expression pattern. Journal of Clinical Endocrinology and Metabolism 82 4258-4265.
19. Foley EF, Jazaeri AA, Shupnik MA, Jazaeri O & Rice LW 2000 Selective loss of estrogen receptor β in malignant human colon. Cancer Research 60 245-248.
20. Garnick MB 1993 Prostate cancer: screening, diagnosis and management. Annals of Internal Medicine 118 804-818.
21. Grigoryev DN, Long BJ, Njar VC & Brodie AH 2000 Pregnenolone stimulates LNCaP prostate cancer cell growth via the mutated androgen receptor. Journal of Steroid Biochemistry and Molecular Biology 75 1-10.
22. Hall JM & McDonnell DP 1999 The estrogen receptor β isoform (ERβ) of the human estrogen receptor modulates ERα transcriptional activity and is a key regulator of the cellular response to estrogens and antiestrogens. Endocrinology 140 5566-5578.
23. Hiramatsu M, Machara I, Orikasa S & Sasano H 1996 Immunolocalization of oestrogen and progesterone receptors in prostatic hyperplasia and carcinoma. Histopathology 28 163-168.
24. Horvath LG, Henshall SM, Lee CS, Head DR, Quinn DI, Makela S, Delprado W, Golovsky D, Brenner PC, O'Neill G, Kooner R, Stricker PD, Grygiel JJ, Gustafsson JA & Sutherland RL 2001 Frequent loss of estrogen receptor-β expression in prostate cancer. Cancer Research 61 5331-5335.
25. Kemppainen JA & Wilson EM 1996 Agonist and antagonist activities of hydroxyflutamide and casodex relate to androgen receptor stabilization. Urology 48 157-163.
26. Kim IY, Kim BC, Seong do H, Lee DK, Seo JM, Hong YJ, Kim HT, Morton RA & Kim SJ 2002 Raloxifene, a mixed estrogen agonist/antagonist, induces apoptosis in androgen-independent human prostate cancer cell lines. Cancer Research 62 5365-5369.
27. Kim IY, Seong do H, Kim BC, Lee DK, Remaley AT, Leach F, Morton RA & Kim SJ 2002 Raloxifene, a selective estrogen receptor modulator, induces apoptosis in androgen-responsive human prostate cancer cell line LNCaP through an androgen-independent pathway. Cancer Research 62 3649-3653.
28. Kirschenbaum A, Ren M, Erenburg I, Schachter B & Levine AC 1994 Estrogen receptor messenger RNA expression in human benign prostatic hyperplasia: detection, localization, and modulation with a long-acting gonadotropin-releasing hormone agonist. Journal of Andrology 15 528-533.
29. Klocker H, Culig Z, Kaspar F, Hobisch A, Eberle J, Reissigl A & Bartsch G 1994 Androgen signal transduction and prostatic carcinoma. World Journal of Urology 12 99-103.
30. Krongard A, Wilson CM, Wilson JD, Allman DR & McPhaul MJ 1991 Androgen increases androgen receptor protein while decreasing receptor mRNA in LNCaP cells. Molecular and Cellular Endocrinology 76 79-88.
31. Kuil CW & Brinkmann AO 1996 Androgens, antiandrogens and androgen receptor abnormalities. European Urology 29 (Suppl 2) 78-82.
32. Kuiper GG, Enmark E, Pelto-Huikko M, Nilsson S & Gustafsson JA 1996 Cloning of a novel receptor expressed in rat prostate and ovary. PNAS 93 5925-5930.
33. Kuiper GG, Carlsson B, Grandien K, Enmnark F, Haggblad J, Nilsson S & Gustafsson J-Å 1997 Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors α and β. Endocrinology 138 863-870.
34. Kumar V, Green S, Stack G, Berry M, Jin JR & Chambon P 1987 Functional domains of the human estrogen receptor. Cell 51 941-951.
35. Lau KM, Leav I & Ho SM 1997 Rat estrogen receptor-α and β and progesterone receptor mRNA expression in various prostatic lobes and microdissected normal and dysplastic epithelial tissues of the Noble rats. Endocrinology 139 424-427.
36. Lau KM, LaSpina M, Long J & Ho SM 2000 Expression of estrogen receptor (ER)-α and ER-β in normal and malignant prostatic epithelial cells: regulation by methylation and involvement in growth regulation. Cancer Research 60 3175-3182.
37. Leav I, Merk FB, Ofner P, Goodrich G, Kwan PW, Stein BM, Sar M & Stumpf WE 1978 Bipotentiality of response to sex hormones by the prostate of castrated or hypophysectomized dogs. Direct effects of estrogen. American Journoal of Pathology 93 69-92.
38. Leav I, Lau KM, Adams JY, McNeal JE, Taplin ME, Wang J, Singh H & Ho SM 2001 Comparativies studies of the estrogen receptors β and α and the androgen receptor in normal human prostate glands, dysplasia and in primary and metastatic carcinoma. American Journal of Pathology 159 79-92.
39. Levine AC, Kirshenbaum A, Droller M & Gabrilove JL 1991 Effect of the addition of estrogen to medical castration on prostatic size, symptoms, histology and serum prostate specific antigen in 4 men with benign prostatic hypertrophy. Journal of Urology 146 790-793.
40. McInerney EM, Weis KE, Sun J, Mosselman S & Katzenellenbogen BS 1998 Transcription activation by the human estrogen receptor subtype β (ER β) studied with ER β and ER α receptor chimeras. Endocrinology 139 4513-4522.
41. Maggiolini M, Donzè O, Jeannin E, Andò S & Picard D 1999 Adrenal androgens stimulate the proliferation of breast cancer cells as direct activators of estrogen receptor α. Cancer Research 59 4864-4869.
42. Maggiolini M, Bonofiglio D, Marsico S, Panno ML, Cenni B, Picard D & Ando S 2001 Estrogen receptor alpha mediates the proliferative but not the cytotoxic dose-dependent effects of two major phytoestrogens on human breast cancer cells. Molecular Pharmacology 60 595-602.
43. Maggiolini M, Vivacqua A, Carpino A, Bonofiglio D, Fasanella G, Salerno M, Picard D & Andò S 2002. The mutant androgen receptor T877A mediates the proliferative but not the cytotoxic dose-dependent effects of genistein and quercetin on human LNCaP prostate cancer cells. Molecular Pharmacology 62 1027-1035.
44. Mawhinney MG & Neubauer BL 1979 Actions of estrogen in the male. Investigative Urology 16 409-420.
45. Merk FB, Warhol MJ, Kwan PW, Leav I, Alroy J, Ofner P & Pinkus GS 1986 Multiple phenotypes of prostatic glandular cells in castrated dogs after individual or combined treatment with androgen and estrogen. Morphometric, ultrastructural and cytochemical distinctions. Laboratory Investigation 54 442-456.
46. Migliaccio A, Castoria G, Di Domenico M, De Falco A, Bilancio A, Lombardi M, Barone MV, Ametrano D, Zannini MS, Abbondanza C & Auricchio F 2000 Steroid-induced androgen receptor-oestradiol receptor β-src complex triggers prostate cancer cell proliferation. EMBO Journal 19 5406-5417.
47. Migliaccio A, Castoria G, Di Domenico M, De Falco A, Bilancio A, Lombardi M, Bottero D, Varricchio L, Nanayakkara M, Rotondi A & Auricchio F 2003 Sex steroid hormones act as growth factors. Journal of Steroid Biochemistry and Molecular Biology 83 31-35.
48. Mosselman S, Polman J & Dijkema R 1996 ER beta: identification and characterization of a novel human estrogen receptor. FEBS Letters 392 49-53.
49. Panet-Raymond V, Gottlieb B, Beitel LK, Pinsky L & Trifiro MA 2000 Interactions between androgen and estrogen receptors and the effects on their transactivational properties. Molecular and Cellular Endocrinology 167 139-150.
50. Parker SL, Tong T, Bolden S & Wingo PA 1997 Cancer statistics. CA: a Cancer Journal for Clinicians 47 5-27.
51. Power KA & Thompson LU 2003 Ligand-induced regulation of ERα and FRβ is indicative of human breast cancer cell proliferation. Breast Cancer Research and Treatment 81 209-221.
52. Pratt WB & Toft DO 1997 Steroid receptor interactions with heat shock protein and immunophillin chaperones. Endocrine Reviews 18 306-360.
53. Prins GS, Marmer M, Woodham C, Chang W, Kuiper G, Gustafsson JA & Birch L 1998 Estrogen receptor-β messenger ribonucleic acid ontogery in the prostate of normal and neonatally estrogenized rats. Endocrinology 139 874-883.
54. Robertson JA, Farnell Y, Lindahl LS & Ing NH 2002 Estradiol up-regulates estrogen receptor messenger ribonucleic acid in endometrial carcinoma (Ishikawa) cells by stabilizing the message. Molecular Endocrinology 29 125-135.
55. Sack JS, Kevin FK, Wang C, Attar RM, Kiefer SE, An Y, Wu GY, Scheffler JE, Salvati ME, Krystek SR, Weimmann R & Einspahr HM 2001 Crystallographic structures of the ligand-binding domains of the androgen receptor and its T877A mutant complexed with the natural agonist dihydrotestosterone. PNAS 98 4904-4909.
56. Santagati S, Gianazza E, Agrati P, Vegeto E, Patrone C, Pollio G & Maggi A 1997 Oligonucleotide squelching reveals the mechanism of estrogen receptor autologous down-regulation. Molecular Endocrinology 11 938-949.
57. Schulze H & Claus S 1990 Histological localization of estrogen receptors in normal and diseased human prostates by immunocytochemistry. Prostate 16 331-343.
58. Skliris GP, Parkes AT, Limer JL, Burdall SE, Carder PJ & Speirs V 2002 Evaluation of seven oestrogen receptor β antibodies for immunohistochemistry, western blotting and flow cytometry in human breast tissue. Journal of Pathology 197 155-162.
59. Suzuki H, Sato N, Watabe Y, Masai M, Seino S & Shimazaki J 1993 Androgen receptor gene mutations in human prostate cancer. Journal of Steroid Biochemistry and Molecular Biology 46 759-765.
60. Tan J, Sharief Y, Hamil KG, Gregory CW, Zang DY, Sar M, Gumerlock PH, White RWV, Pretlow TG, Harris SE, Wilson EM, Mohler JL & French FS 1997 Dehydroepiandrosterone activates mutant androgen receptors expressed in the androgen-dependent human prostate cancer xenograft CWR22 and LNCaP cells. Molecular Endocrinology 11 450-459.
61. Taplin ME & Ho SM 2001 The endocrinology of prostate cancer. Journal of Clinical Endocrinology and Metabolism 86 3467-3477.
62. Tremblay GB, Tremblay A, Copeland NG, Gilbert DJ, Jenkins NA, Labrie F & Giguère V 1997 Cloning, chromosomal localization and functional analysis of the murine estrogen receptor β. Molecular Endocrinology 11 353-362.
63. Tsai MJ & O'Malley BW 1994 Molecular mechanisms of action of steroid/thyroid receptor superfamily members. Annual Reviews of Biochemistry 63 451-486.
64. Veldscholte J, Ris-Stalpers C, Kuiper GG, Jenster G, Berrevoets C, Claassen E, van Rooij HCJ, Trapmann J, Brinkmann AO & Mulder E 1990 A mutation in the ligand binding domain of the androgen receptor of human LNCaP cells affects steroid binding characteristics and response to antiandrogens. Biochemical and Biophysical Research Communications 173 534-540.
65. Webber MM, Bello D & Quader S 1997 Immortalized and tumorigenic adult human prostatic epithelial cell lines: characteristics and applications. Part 2. Tumorigenic cell lines. Prostate 30 58-64.
66. Weihua Z, Makela S, Andersson LC, Salmi S, Saji S, Webster JI, Jensen EV, Nilsson S, Warner M & Gustafsson JA 2001 A role for estrogen receptor beta in the regulation of growth of the ventral prostate. PNAS 98 6330-6335.
67. Wingo PA, Landis S & Ries LAG 2001 An adjustment to the 1997 estimate for new Prostate cancer cases. CA: a Cancer Journal for Clinicians 47 239-242.
68. Yeap BB, Krueger RG & Leedman PJ 1999 Differential posttranscriptional regulation of androgen receptor gene expression by androgen in prostate and breast cancer cells. Endocrinology 140 3282-3291.
69. Yeh S & Chang C 1996 Cloning and characterization of a specific coactivator, ARA70, for the androgen receptor in human prostate cells. PNAS 93 5517-5521.
70. Yeh S, Miyamoto H, Shima H & Chang C 1998 From estrogen to androgen receptor: a new pathway for sex hormones in prostate. PNAS 95 5527-5532.
71. Zhou ZX, Lane MV, Kemppainen JA, French FS & Wilson EM 1995 Specificity of ligand-dependent androgen receptor stabilization: receptor domain interactions influence ligand dissociation and receptor stability. Molecular Endocrinology 9 208-218.